Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Pfizer Inc. (PFE) had Normalized Income after Taxes of $-1.64B for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$17.56B |
|
$-1.65B |
|
$5.27B |
|
$12.29B |
|
$14.69B |
|
$2.87B |
|
$-4.51B |
|
$-1.64B |
|
$-1.64B |
|
$-1.64B |
|
$-1.64B |
|
$-1.64B |
|
|
Normalized Income after Taxes |
$-1.64B |
$2.87B |
|
-- |
|
5.69B |
|
5.69B |
|
$-0.29 |
|
$-0.29 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|